<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: human gene</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Researchers create map of 'shortcuts' between all human genes</title>
   	 <description>Some diseases are caused by single gene mutations. Current techniques for identifying the disease-causing gene in a patient produce hundreds of potential gene candidates, making it difficult for scientists to pinpoint the single causative gene. Now, a team of researchers led by Rockefeller University scientists have created a map of gene &quot;shortcuts&quot; to simplify the hunt for disease-causing genes.</description>
     <link>http://medicalxpress.com/news/2013-03-shortcuts-human-genes.html</link>
	 <category>Genetics</category>
	 <pubDate>Mon, 18 Mar 2013 17:10:47 EST</pubDate>
	 <guid isPermaLink="false">news282845412</guid>
	 
</item>
<item>
     <title>Novel treatment approach for bladder pain using a herpes simplex virus vector reported</title>
   	 <description>Severe chronic pain associated with conditions such as bladder pain syndrome/interstitial cystitis often require the use of opioid medication, with the risk of dependency and serious adverse reactions. An alternative treatment strategy increases the levels of a naturally occurring painkiller in and around the nerves that deliver pain signals to the bladder. This new therapeutic approach is described in an article in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.</description>
     <link>http://medicalxpress.com/news/2013-03-treatment-approach-bladder-pain-herpes.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 14 Mar 2013 13:03:51 EST</pubDate>
	 <guid isPermaLink="false">news282485022</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/1-noveltreatme.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers show that lipid nanoparticles are ideal for delivering genes and drugs</title>
   	 <description>Researchers from Basque Public University are using nanotechnology to develop new formulations that can be applied to drugs and gene therapy. Specifically, they are using nanoparticles to design systems for delivering genes and drugs; this helps to get the genes and drugs to the point of action so that they can produce the desired effect.</description>
     <link>http://medicalxpress.com/news/2013-02-lipid-nanoparticles-ideal-genes-drugs.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 28 Feb 2013 10:53:45 EST</pubDate>
	 <guid isPermaLink="false">news281271176</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/12-researcherss.jpg" width="90" height="90" />
</item>
<item>
     <title>Less tau reduces seizures and sudden death in severe epilepsy</title>
   	 <description>Deleting or reducing expression of a gene that carries the code for tau, a protein associated with Alzheimer's disease, can prevent seizures in a severe type of epilepsy linked to sudden death, said researchers at Baylor College of Medicine and the Mayo Clinic in Jacksonville, Fla., in a report in the current issue of the Journal of Neuroscience.</description>
     <link>http://medicalxpress.com/news/2013-01-tau-seizures-sudden-death-severe.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Tue, 22 Jan 2013 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news278090923</guid>
	 
</item>
<item>
     <title>Lack of key enzyme in the metabolism of folic acid leads to birth defects</title>
   	 <description>Researchers at The University of Texas at Austin have discovered that the lack of a critical enzyme in the folic acid metabolic pathway leads to neural tube birth defects in developing embryos.</description>
     <link>http://medicalxpress.com/news/2013-01-lack-key-enzyme-metabolism-folic.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 17 Jan 2013 13:23:45 EST</pubDate>
	 <guid isPermaLink="false">news277651417</guid>
	 
</item>
<item>
     <title>Australian study turns HIV against itself (Update)</title>
   	 <description>An Australian scientist said Wednesday he had discovered a way to turn the HIV virus against itself in human cells in the laboratory, in an important advance in the quest for an AIDS cure.</description>
     <link>http://medicalxpress.com/news/2013-01-australian-potential-aids.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 16 Jan 2013 05:36:02 EST</pubDate>
	 <guid isPermaLink="false">news277536956</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/filepicturea.jpg" width="90" height="90" />
</item>
<item>
     <title>Study suggests human genes influence gut microbial composition</title>
   	 <description>New research led by the Karolinska Institutet, Sweden and the University of Glasgow, Scotland, has identified a link between a human gene and the composition of human gastrointestinal bacteria. In a study published as a letter to the journal Gut, the team outline new evidence suggesting that the human genome may play a role in determining the makeup of the billions of microbes in the human gastrointestinal tract collectively known as the gut microbiota.</description>
     <link>http://medicalxpress.com/news/2013-01-human-genes-gut-microbial-composition.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 07 Jan 2013 04:40:38 EST</pubDate>
	 <guid isPermaLink="false">news276756030</guid>
	 
</item>
<item>
     <title>Rebuilding blood vessels through gene therapy</title>
   	 <description>(Medical Xpress)—Diagnosed with severe coronary artery disease, a group of patients too ill for or not responding to other treatment options decided to take part in a clinical trial testing angiogenic gene therapy to help rebuild their damaged blood vessels. More than 10 years later, in a follow-up review of these patients, doctors at Baylor College of Medicine, Weill Cornell Medical College (where the clinical trial and review took place) and Stony Brook University Medical Center report the outcomes are promising and open the door for larger trials to begin.</description>
     <link>http://medicalxpress.com/news/2012-12-rebuilding-blood-vessels-gene-therapy.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 21 Dec 2012 08:16:46 EST</pubDate>
	 <guid isPermaLink="false">news275300096</guid>
	 
</item>
<item>
     <title>Researchers produce a catalog of the deleterious and disease-causing genetic variants in healthy people</title>
   	 <description>Researchers at Cambridge and Cardiff have found that, on average, a normal healthy person carries approximately 400 potentially damaging DNA variants and two variants known to be associated directly with disease traits. They showed that one in ten people studied is expected to develop a genetic disease as a consequence of carrying these variants.</description>
     <link>http://medicalxpress.com/news/2012-12-deleterious-disease-causing-genetic-variants-healthy.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 06 Dec 2012 12:00:42 EST</pubDate>
	 <guid isPermaLink="false">news274004951</guid>
	 
</item>
<item>
     <title>First gene therapy to go on sale in Europe in 2013</title>
   	 <description>Dutch biotech company uniQure said Monday it would start selling the first human gene therapy to be approved in the West by mid-2013 and predicted an explosion of similar therapies to come.</description>
     <link>http://medicalxpress.com/news/2012-11-gene-therapy-sale-europe.html</link>
	 <category>Genetics</category>
	 <pubDate>Mon, 05 Nov 2012 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news271343570</guid>
	 
</item>
<item>
     <title>New anti-tumor cell therapy strategies are more effective</title>
   	 <description>Targeted T-cells can seek out and destroy tumor cells that carry specific antigen markers. Two novel anti-tumor therapies that take advantage of this T-cell response are described in articles published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The articles are available free on the Human Gene Therapy website.</description>
     <link>http://medicalxpress.com/news/2012-10-anti-tumor-cell-therapy-strategies-effective.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 25 Oct 2012 13:04:18 EST</pubDate>
	 <guid isPermaLink="false">news270388959</guid>
	 
</item>
<item>
     <title>Cutting through the genomic thicket in search of disease variants</title>
   	 <description>(Medical Xpress)—In the early stages of that vast undertaking known as the Human Genome Project, enthusiasm ran high. The enterprise would be costly and laborious but the clinical rewards, unprecedented. Once the complete blueprint of life was unlocked, the genetic underpinnings for a broad range of human maladies would be laid bare, allowing custom-tailored diagnosis and treatment and revolutionizing the field of medicine.</description>
     <link>http://medicalxpress.com/news/2012-09-genomic-thicket-disease-variants.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 25 Sep 2012 09:34:32 EST</pubDate>
	 <guid isPermaLink="false">news267784453</guid>
	 
</item>
<item>
     <title>Scientists reverse Alzheimer's-like memory loss in animal models by blocking EGFR signaling</title>
   	 <description>A team of neuroscientists and chemists from the U.S. and China today publish research suggesting that a class of currently used anti-cancer drugs as well as several previously untested synthetic compounds show effectiveness in reversing memory loss in two animal models of Alzheimer's' disease.</description>
     <link>http://medicalxpress.com/news/2012-09-scientists-reverse-alzheimer-like-memory-loss.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 24 Sep 2012 16:35:33 EST</pubDate>
	 <guid isPermaLink="false">news267721729</guid>
	 
</item>
<item>
     <title>Discovery may shed light on why some HIV-positive patients have more virus</title>
   	 <description>(Medical Xpress)—Biologists at UC San Diego have unraveled the anti-viral mechanism of a human gene that may explain why some people infected with HIV have much higher amounts of virus in their bloodstreams than others.</description>
     <link>http://medicalxpress.com/news/2012-09-discovery-hiv-positive-patients-virus.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 24 Sep 2012 07:10:48 EST</pubDate>
	 <guid isPermaLink="false">news267689428</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/3-discoverymay.jpg" width="90" height="90" />
</item>
<item>
     <title>Enlisting the AIDS virus to fight cancer</title>
   	 <description>(Medical Xpress)—Can HIV be transformed into a biotechnological tool for improving human health? According to a CNRS team at the Architecture et Réactivité de l'ARN (RNA Architecture and Reactivity) laboratory, the answer is yes. Taking advantage of the HIV replication machinery, the researchers have been able to select a specific mutant protein. Added to a culture of tumor cells in combination with an anticancer drug, this protein improves the effectiveness of the treatment at 1/300 the normal dosage levels. Published in PLoS Genetics on 23 August 2012, these findings could lead to long-term therapeutic applications in the treatment of cancer and other pathologies.</description>
     <link>http://medicalxpress.com/news/2012-08-aids-virus-cancer.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 29 Aug 2012 07:55:40 EST</pubDate>
	 <guid isPermaLink="false">news265445555</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/enlistingthe.jpg" width="90" height="90" />
</item>
<item>
     <title>Marin County's high breast cancer rate may be tied to genetics</title>
   	 <description>(Medical Xpress) -- Marin County, California has one of the highest rates of breast cancer in the world, a fact that scientists know has nothing to do with the land itself but with some other, unknown factor.</description>
     <link>http://medicalxpress.com/news/2012-08-marin-county-high-breast-cancer.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 08 Aug 2012 09:39:34 EST</pubDate>
	 <guid isPermaLink="false">news263637565</guid>
	 
</item>
<item>
     <title>Method to prevent rejection of disease-fighting proteins described</title>
   	 <description>The body's natural reaction to reject replacement proteins represents a major obstacle to the successful use of gene therapy to cure a range of life-threatening diseases. A novel method that uses the body's own immune cells to induce tolerance to a specific protein was shown to suppress the rejection response, as described in an article in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc. </description>
     <link>http://medicalxpress.com/news/2012-08-method-disease-fighting-proteins.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 07 Aug 2012 13:16:37 EST</pubDate>
	 <guid isPermaLink="false">news263564190</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/methodtoprev.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers discover elusive gene that causes Leber congenital amaurosis</title>
   	 <description>Researchers from the Massachusetts Eye and Ear Infirmary, The Children's Hospital of Philadelphia, Loyola University Chicago Health Sciences Division and their collaborators have isolated an elusive human gene that causes a common form of Leber congenital amaurosis (LCA), a relatively rare but devastating form of early-onset blindness. The new LCA gene is called NMNAT1. Finding the specific gene mutated in patients with LCA is the first step towards developing sight-saving gene therapy.</description>
     <link>http://medicalxpress.com/news/2012-07-elusive-gene-leber-congenital-amaurosis.html</link>
	 <category>Genetics</category>
	 <pubDate>Sun, 29 Jul 2012 13:00:11 EST</pubDate>
	 <guid isPermaLink="false">news262780124</guid>
	 
</item>
<item>
     <title>Gene variant reduces cholesterol by two mechanisms</title>
   	 <description>High levels of low-density lipoprotein (LDL) cholesterol increases the risk for coronary heart disease. </description>
     <link>http://medicalxpress.com/news/2012-07-gene-variant-cholesterol-mechanisms.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 02 Jul 2012 12:00:11 EST</pubDate>
	 <guid isPermaLink="false">news260448918</guid>
	 
</item>
<item>
     <title>Targeted gene therapy enhances treatment for Pompe disease</title>
   	 <description>Gene therapy to replace the protein missing in Pompe disease can be effective if the patient's immune system does not react against the therapy. Targeted delivery of the gene to the liver, instead of throughout the body,suppresses the immune response, improving the therapeutic effect, according to an article published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc. The article is available free online at the Human Gene Therapy website.</description>
     <link>http://medicalxpress.com/news/2012-06-gene-therapy-treatment-pompe-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 25 Jun 2012 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news259848728</guid>
	 
</item>
<item>
     <title>New advances in treating inherited retinal diseases highlighted in Human Gene Therapy</title>
   	 <description>Gene therapy strategies to prevent and treat inherited diseases of the retina that can cause blindness have progressed rapidly. Positive results in animal models of human retinal disease continue to emerge, as reported in several articles published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The articles are available free on the Human Gene Therapy website at http://www.liebertpub.com/hum.</description>
     <link>http://medicalxpress.com/news/2012-05-advances-inherited-retinal-diseases-highlighted.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 08 May 2012 12:51:42 EST</pubDate>
	 <guid isPermaLink="false">news255700295</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newadvancesi.jpg" width="90" height="90" />
</item>
<item>
     <title>Extra gene drove instant leap in human brain evolution</title>
   	 <description>A partial, duplicate copy of a gene appears to be responsible for the critical features of the human brain that distinguish us from our closest primate kin. The momentous gene duplication event occurred about two or three million years ago, at a critical transition in the evolution of the human lineage, according to a pair of studies published early online in the journal Cell, a Cell Press publication, on May 3rd.</description>
     <link>http://medicalxpress.com/news/2012-05-extra-gene-drove-instant-human.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 03 May 2012 14:10:02 EST</pubDate>
	 <guid isPermaLink="false">news255270918</guid>
	 
</item>
<item>
     <title>New genetically engineered mice aid understanding of incurable neuromuscular disease</title>
   	 <description>A team of scientists from the University of Missouri created a genetically modified mouse that mimics key features of Charcot-Marie-Tooth disease, an inherited neuromuscular disease affecting approximately 150,000 people in the United States.</description>
     <link>http://medicalxpress.com/news/2012-04-genetically-mice-aid-incurable-neuromuscular.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 17 Apr 2012 13:08:20 EST</pubDate>
	 <guid isPermaLink="false">news253886739</guid>
	 
</item>
<item>
     <title>Researchers find critical regulator to tightly control deadly pulmonary fibrosis</title>
   	 <description>An international team of researchers led by Georgia State University scientists have found a key component in the pathological process of pulmonary fibrosis, a fatal disease for which there is currently no cure.</description>
     <link>http://medicalxpress.com/news/2012-04-critical-tightly-deadly-pulmonary-fibrosis.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 10 Apr 2012 11:20:28 EST</pubDate>
	 <guid isPermaLink="false">news253275595</guid>
	 
</item>
<item>
     <title>Asthma: A vaccination that works using intramuscular injection</title>
   	 <description>Asthma is a chronic inflammatory and respiratory disease caused by an abnormal reactivity to allergens in the environment. Of the several avenues of exploration that are currently being developed, vaccination appears to be the most promising approach. In a publication soon to appear in the review Human Gene Therapy, the research scientists at Inserm and CNRS ( Institut du thorax, CNRS, France) reveal an innovatory vaccine against one of the allergens most frequently encountered in asthma patients. After vaccine was directly injected into the muscle of an asthmatic mouse, a nanovector significantly reduced both the hypersensitivity to the allergen and the associated inflammatory response.</description>
     <link>http://medicalxpress.com/news/2012-04-asthma-vaccination-intramuscular.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Wed, 04 Apr 2012 10:22:50 EST</pubDate>
	 <guid isPermaLink="false">news252753756</guid>
	 
</item>
<item>
     <title>Genetics of flu susceptibility: Researchers find gene that can transform mild influenza to a life-threatening disease</title>
   	 <description>A genetic finding could help explain why influenza becomes a life-threating disease to some people while it has only mild effects in others. New research led by the Wellcome Trust Sanger Institute has identified for the first time a human gene that influences how we respond to influenza infection.</description>
     <link>http://medicalxpress.com/news/2012-03-genetics-flu-susceptibility-gene-mild.html</link>
	 <category>Genetics</category>
	 <pubDate>Sun, 25 Mar 2012 13:57:05 EST</pubDate>
	 <guid isPermaLink="false">news251902604</guid>
	 
</item>
<item>
     <title>Gene therapy is a 'disruptive science' ready for commercial development</title>
   	 <description>The time for commercial development of gene therapy has come. Patients with diseases treatable and curable with gene therapy deserve access to the technology, which has demonstrated both its effectiveness and feasibility, says James Wilson, MD, PhD, Editor-in-Chief of Human Gene Therapy in a provocative commentary and accompanying videocast. Human Gene Therapy and Human Gene Therapy (HGT) Methods are peer-reviewed journals published by Mary Ann Liebert, Inc..</description>
     <link>http://medicalxpress.com/news/2012-01-gene-therapy-disruptive-science-ready.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 24 Jan 2012 12:55:55 EST</pubDate>
	 <guid isPermaLink="false">news246632138</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/genetherapyi.jpg" width="90" height="90" />
</item>
<item>
     <title>New gene therapy methods accurately correct mutation in patient's stem cells</title>
   	 <description>For the first time, scientists have cleanly corrected a human gene mutation in a patient's stem cells. The result, reported in Nature on Wednesday 12 October, brings the possibility of patient-specific therapies closer to becoming a reality.</description>
     <link>http://medicalxpress.com/news/2011-10-gene-therapy-methods-accurately-mutation.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 12 Oct 2011 13:00:20 EST</pubDate>
	 <guid isPermaLink="false">news237637269</guid>
	 
</item>
<item>
     <title>Discovery may lead to mitochndria syndrome treatment</title>
   	 <description>Mitochondrial depletion syndrome accounts for about 11 percent of the cases of children born with common myopathies and a more mild form of the syndrome affecting adults. A new finding by Cornell researchers may lead to a nutrition-based treatment with B vitamins.</description>
     <link>http://medicalxpress.com/news/2011-09-discovery-mitochndria-syndrome-treatment.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 22 Sep 2011 06:12:52 EST</pubDate>
	 <guid isPermaLink="false">news235890724</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/discoverymay.jpg" width="90" height="90" />
</item>
<item>
     <title>Gene gives clues to self-injurious behavior in rare disorder</title>
   	 <description>In humans, inherited mutations in a gene called HPRT1 lead to very specific self-destructive behavior. Boys with Lesch-Nyhan disease experience uncontrollable urges to bite their fingers, slam their arms into doorways and otherwise harm themselves.</description>
     <link>http://medicalxpress.com/news/2011-07-gene-clues-self-injurious-behavior-rare.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 27 Jul 2011 17:00:04 EST</pubDate>
	 <guid isPermaLink="false">news231001165</guid>
	 
</item>


</channel>
</rss>
